Clinical Trial Update: Second Line Breast Cancer Trial [Phase 3]

View source ↗

Summary

Phase 3 trial in second-line advanced breast cancer sponsored by AstraZeneca has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Advanced Breast Cancer | Phase 3 | Status: COMPLETED